Viewing Study NCT00973895


Ignite Creation Date: 2025-12-24 @ 2:16 PM
Ignite Modification Date: 2026-01-01 @ 12:31 AM
Study NCT ID: NCT00973895
Status: COMPLETED
Last Update Posted: 2017-07-02
First Post: 2009-09-05
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: VRC 308: An Open-Label Phase I Study of the Safety and Immunogenicity of an Investigational H1 DNA Influenza Vaccine, VRC-FLUDNA057-00-VP, in Healthy Adults 18-70 Years Old
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2009-08-06
Start Date Type: None
Primary Completion Date: 2010-09-03
Primary Completion Date Type: ACTUAL
Completion Date: 2010-09-03
Completion Date Type: ACTUAL
First Submit Date: 2009-09-05
First Submit QC Date: None
Study First Post Date: 2009-09-09
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2017-06-30
Last Update Post Date: 2017-07-02
Last Update Post Date Type: ACTUAL